19-28z CAR T-Cell Efficacy and Toxicity in Adults With R/R B-Cell ALL
Slideset - Preinfusion disease burden associated with increased rates of cytokine release syndrome after 19-28z CAR-modified T-cell therapy. (Source: Clinical Care Options Leukemia)
Source: Clinical Care Options Leukemia - June 6, 2016 Category: Hematology Source Type: research
Venetoclax + Low-Dose Cytarabine in Elderly Patients With Untreated AML
Slideset - Early-phase study suggests promise of venetoclax plus low-dose cytarabine in untreated elderly patients with acute myeloid leukemia. (Source: Clinical Care Options Leukemia)
Source: Clinical Care Options Leukemia - June 6, 2016 Category: Hematology Source Type: research
Addressing Financial Challenges With Use of New Immunotherapies for Relapsed ALL
Discussion - How do you manage the potential financial challenges to prescribing blinatumomab and other novel immunotherapies for your patients who may benefit from these therapies? (Source: Clinical Care Options Leukemia)
Source: Clinical Care Options Leukemia - May 19, 2016 Category: Hematology Source Type: research
Chronic Lymphocytic Leukemia: New Therapeutic Strategies for the Practicing Clinician
Video - Watch this video from a live meeting with Jeffrey A. Jones, MD, MPH, as he presents key concepts related to disease management and individualized treatment selection for patients with CLL. (Source: Clinical Care Options Leukemia)
Source: Clinical Care Options Leukemia - May 10, 2016 Category: Hematology Source Type: research
B-Cell Malignancies: New Therapeutic Strategies for the Practicing Clinician (Chronic Lymphocytic Leukemia)
Slideset - In this downloadable slideset, Jennifer Brown, MD, PhD, reviews key studies in the management of patients with chronic lymphocytic leukemia. (Source: Clinical Care Options Leukemia)
Source: Clinical Care Options Leukemia - April 28, 2016 Category: Hematology Source Type: research
Expert Guidance in Chronic Lymphocytic Leukemia: Applying New Developments to Clinical Practice
Learning Module - Farrukh Awan, MD, MS, and Jacqueline Barrientos, MD, provide an in-depth look at current standards and recent changes in the treatment landscape for chronic lymphocytic leukemia and provide their expert perspectives on how to best use new agents and approaches in the clinic. (Source: Clinical Care Options Leukemia)
Source: Clinical Care Options Leukemia - April 28, 2016 Category: Hematology Source Type: research
How I Individualize Frontline CLL Therapy in My Practice
Discussion - I discuss experience-based and evidence-based rationale behind frontline treatment selection for individual patients with CLL and highlight an online treatment decision aid that you can use. (Source: Clinical Care Options Leukemia)
Source: Clinical Care Options Leukemia - March 29, 2016 Category: Hematology Source Type: research
ClinicalThought: Cancer Immunotherapy
Learning Module - In this CME-certified educational module, CCO’s expert faculty examine the latest immunotherapeutic options, with associated adverse events, as well as their seamless integration into the clinical management of patients with various malignancies. (Source: Clinical Care Options Leukemia)
Source: Clinical Care Options Leukemia - March 23, 2016 Category: Hematology Source Type: research
Acute and Chronic Leukemias
Learning Module - In this Expert Analysis, Elias Jabbour, MD, and Farhad, MD, review and discuss the clinical relevance of key studies in acute and chronic leukemias presented at the 2015 ASH annual meeting. (Source: Clinical Care Options Leukemia)
Source: Clinical Care Options Leukemia - February 26, 2016 Category: Hematology Source Type: research
New Immunotherapeutic Combinations for Hematologic Malignancies
Discussion - Explore the latest immunotherapeutic combinations for treatment of hematologic malignancies. (Source: Clinical Care Options Leukemia)
Source: Clinical Care Options Leukemia - February 26, 2016 Category: Hematology Source Type: research
Changing Clinical Practice in CLL
Discussion - Review my insights on recently presented data in the rapid evolution of management approaches for CLL. (Source: Clinical Care Options Leukemia)
Source: Clinical Care Options Leukemia - February 25, 2016 Category: Hematology Source Type: research
Immunotherapies and Other Novel Treatment Strategies for the Management of Ph-Negative Acute Lymphocytic Leukemia: Best Practices and Future Directions
Learning Module - In this CME-certified module, Dan Douer, MD, provides a comprehensive review of treatment for Philadelphia chromosome–negative adult ALL, including patient and disease factors influencing therapeutic decisions, and his insights on the emergence of immunotherapeutic options. (Source: Clinical Care Options Leukemia)
Source: Clinical Care Options Leukemia - February 18, 2016 Category: Hematology Source Type: research
Immunotherapies and Other Novel Treatment Strategies for the Management of Ph-Negative Acute Lymphocytic Leukemia: Best Practices and Future Directions
Slideset - In this downloadable slideset, Dan Douer, MD, reviews novel strategies and current guideline recommendations for treating patients with Philadelphia chromosome–negative ALL, with a focus on the latest evidence surrounding approved and investigational immunotherapeutics. (Source: Clinical Care Options Leukemia)
Source: Clinical Care Options Leukemia - February 18, 2016 Category: Hematology Source Type: research
What You Need to Know About CAR T Cells
Discussion - CAR T-cell therapeutics have been big news this year—here is what you need to know. (Source: Clinical Care Options Leukemia)
Source: Clinical Care Options Leukemia - February 4, 2016 Category: Hematology Source Type: research
